Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. aTyr Pharma's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was $0.00 Mil. aTyr Pharma's average total debt for the quarter that ended in Dec. 2023 was $15.16 Mil. Therefore, aTyr Pharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 0.00%.
aTyr Pharma Effective Interest Rate on Debt % Historical Data
The historical data trend for aTyr Pharma's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, aTyr Pharma's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aTyr Pharma Effective Interest Rate on Debt % Distribution
For the Biotechnology industry and Healthcare sector, aTyr Pharma's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where aTyr Pharma's Effective Interest Rate on Debt % falls into.
aTyr Pharma Effective Interest Rate on Debt % Calculation
aTyr Pharma's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data,
the Interest Expense data used here is four times the quarterly (Dec. 2023) interest expense data.
Effective Interest Rate on Debt % is displayed in the 30-year financial page.
aTyr Pharma (NAS:LIFE) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
aTyr Pharma Effective Interest Rate on Debt % Related Terms
Thank you for viewing the detailed overview of aTyr Pharma's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LIFE has been successfully added to your 